Your browser doesn't support javascript.
loading
Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL).
Annemans, Lieven; Aymé, Ségolène; Le Cam, Yann; Facey, Karen; Gunther, Penilla; Nicod, Elena; Reni, Michele; Roux, Jean-Louis; Schlander, Michael; Taylor, David; Tomino, Carlo; Torrent-Farnell, Josep; Upadhyaya, Sheela; Hutchings, Adam; Le Dez, Lugdivine.
Afiliación
  • Annemans L; Department of Public Health, Ghent University, Ghent, Belgium.
  • Aymé S; ICM, CNRS UMR 7225--Inserm U 1127--UPMC-P6 UMR S 1127, Paris, France.
  • Le Cam Y; EURORDIS-Rare Diseases Europe, Paris, France.
  • Facey K; University of Edinburgh, Edinburgh, Scotland.
  • Gunther P; Swedish Parliament, Stockholm, Sweden.
  • Nicod E; Centre for Research on Health and Social Care Management (CERGAS), Bocconi University, Milan, Italy.
  • Reni M; IRCCS Ospedale San Raffaele Scientific Institute, Milan, Italy.
  • Roux JL; EURORDIS-Rare Diseases Europe, Paris, France.
  • Schlander M; Health Economics at the University of Heidelberg, Heidelberg, Germany.
  • Taylor D; Division of Health Economics at the German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Tomino C; Institute for Innovation & Valuation in Health Care, Wiesbaden, Germany.
  • Torrent-Farnell J; Pharmaceutical and Public Health Policy, University College London (UCL), London, UK.
  • Upadhyaya S; Clinical Research at IRCSS San Raffaele, Rome, Italy.
  • Hutchings A; Clinical Pharmacology and Therapeutics, Autonomous University of Barcelona, Barcelona, Spain.
  • Le Dez L; NICE, Manchester, UK.
Orphanet J Rare Dis ; 12(1): 50, 2017 03 10.
Article en En | MEDLINE | ID: mdl-28283046
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Producción de Medicamentos sin Interés Comercial / Enfermedades Raras Tipo de estudio: Health_technology_assessment / Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Orphanet J Rare Dis Asunto de la revista: MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Producción de Medicamentos sin Interés Comercial / Enfermedades Raras Tipo de estudio: Health_technology_assessment / Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Orphanet J Rare Dis Asunto de la revista: MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Bélgica